ABBOTT LABORATORIES (ABT)
Clinical trial NCT05493904: enrollment: not set → 320 participants.
MASIMO CORP (MASI)
Clinical trial NCT06232876 updates: 1. start date: 2025-11-01 → 2026-06-01 2. completion date: 2026-11-01 → 2029-03-01 3. primary completion date: 2026-11-01 → 2028-07-01 4. enrollment: not set → 492 participants
RESMED INC. (RSMDF)
Clinical trial NCT05911646 updates: 1. completion date: 2026-01-31 → 2027-05-31 2. primary completion date: 2026-01-31 → 2026-10-31 3. enrollment: not set → 130 participants
ELUTIA INC. (ELUT)
Clinical trial NCT06854081 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 100 participants
LEXICON PHARMACEUTICALS, INC. (LXRX)
Clinical trial NCT06079281: enrollment: not set → 124 participants.
BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT05503173 updates: 1. completion date: 2026-05-01 → 2026-12-01 2. primary completion date: 2026-05-01 → 2026-12-01 3. enrollment: not set → 385 participants
INNOVENT BIOLOGICS INC. (IVBIY)
Clinical trial NCT05890742 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 453 participants
GE HEALTHCARE TECHNOLOGIES INC. (GEHC)
Clinical trial NCT04974710: enrollment: not set → 100 participants.
ASTRAZENECA PLC (AZN)
Clinical trial NCT07427394 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-10 → 2026-05-06 3. enrollment: not set → 24 participants
AMGEN INC (AMGN)
Clinical trial NCT06593522 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2030-11-29 → 2026-11-30 3. primary completion date: 2028-11-29 → 2026-10-31 4. enrollment: not set → 61 participants